Literature DB >> 9205026

Effect of fluvastatin on low-density lipoprotein peak particle diameter.

H R Superko1, R M Krauss, C DiRicco.   

Abstract

The effect of fluvastatin on low-density lipoprotein (LDL) particle diameter was investigated in 42 hypercholesterolemic patients. Fluvastatin reduced LDL cholesterol significantly but had no effect on LDL particle diameter; it also had no differential effect on patients classified as LDL pattern A (large LDL), pattern B (small LDL), or I (intermediate LDL).

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9205026     DOI： 10.1016/s0002-9149(97)00288-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  6 in total

1.  Small, dense, low-density lipoprotein and atherosclerosis.

Authors:  H R Superko
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Statins do not decrease small, dense low-density lipoprotein.

Authors:  Cheol Ung Choi; Hong Seog Seo; Eun Mi Lee; Seung Yong Shin; Un-Jung Choi; Jin Oh Na; Hong Euy Lim; Jin Won Kim; Eung Ju Kim; Seung-Woon Rha; Chang Gyu Park; Dong Joo Oh
Journal:  Tex Heart Inst J       Date:  2010

3.  Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.

Authors:  Samia Mora; Michael P Caulfield; Jay Wohlgemuth; Zhihong Chen; H Robert Superko; Charles M Rowland; Robert J Glynn; Paul M Ridker; Ronald M Krauss
Journal:  Circulation       Date:  2015-09-25       Impact factor: 29.690

Review 4.  Small, dense low-density lipoprotein subclass pattern B: issues for the clinician.

Authors:  H R Superko
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

5.  Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy.

Authors:  William Insull; Peter P Toth; H Robert Superko; Roopal B Thakkar; Scott Krause; Ping Jiang; Rhea A Parreno; Robert J Padley
Journal:  Vasc Health Risk Manag       Date:  2010-11-24

Review 6.  CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?

Authors:  Christian Abendstein Kjellmo; Anders Hovland; Knut Tore Lappegård
Journal:  Diseases       Date:  2018-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.